Pfizer (MIC:PFE-RM) Other Financing: $-387.00 Mil (TTM As of Mar. 2026)


What is Pfizer Other Financing?

Pfizer MIC:PFE-RM 74 Other Financing is $-387.00 Mil as of Mar. 2026. GuruFocus rates MIC:PFE-RM with a GF Score™ of 74/100. The stock has 5 warning signs investors should review.

Pfizer's Other Financing for the three months ended in Mar. 2026 was $-284.00 Mil.

Pfizer's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $-387.00 Mil.

Pfizer Other Financing Historical Data

* Premium members only.

The historical data trend for Pfizer's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Other Financing Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.00 -335.00 -632.00 -469.00 -459.00

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -356.00 -20.00 -39.00 -44.00 -284.00

Pfizer Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-387.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-387.00 Mil mean?
Pfizer (MIC:PFE-RM) has a Other Financing of $-387.00 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Pfizer and its competitors.
Is Pfizer's Other Financing too high?
Pfizer's current Other Financing is $-387.00 Mil. Overall, Pfizer has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Other Financing compare to GILD and BMY?
Pfizer's Other Financing of $-387.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Pfizer and its competitors. Pfizer's current Other Financing is $-387.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Pfizer (MIC:PFE-RM) has a current Other Financing of $-387.00 Mil. The current Other Financing is $-387.00 Mil. Pfizer's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Pfizer (MIC:PFE-RM), the current Other Financing is $-387.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.